Cholesterol, Elevated Clinical Trial
Official title:
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Elevated Cholesterol
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Elevated Cholesterol.
The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to the information provided in surveys and in medical records regarding Elevated Cholesterol. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01702883 -
The Medication Experience Study
|
N/A | |
| Completed |
NCT03397121 -
Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)
|
Phase 3 | |
| Completed |
NCT03400800 -
Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol
|
Phase 3 | |
| Terminated |
NCT01634646 -
Observational Study of Lyzme5 Impact on Cholesterol and Body Weight in Man
|
N/A | |
| Completed |
NCT02990637 -
The Effect of Olive Leaf Extract Administration on Cardiovascular Health
|
N/A | |
| Completed |
NCT03134235 -
Effects of a 4-week Raw, Plant-based Diet on Anthropometric and Cardiovascular Risk Factors
|
N/A | |
| Completed |
NCT05091073 -
A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants
|
Phase 1 | |
| Enrolling by invitation |
NCT04798430 -
Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
|
Phase 3 | |
| Completed |
NCT03399370 -
Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
|
Phase 3 | |
| Completed |
NCT03814187 -
Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C
|
Phase 3 |